# Graded activation of mutant K41C-KCNE1:KCNQ1 channel complexes by mefenamic acid

**Authors:** Yundi Wang, Magnus Chan, Marc Pourrier, Jodene Eldstrom, David Fedida

PMC · DOI: 10.1080/19336950.2025.2539494 · Channels · 2025-07-29

## TL;DR

This study explores how mefenamic acid activates potassium channels in the heart and how a mutation affects this process.

## Contribution

The study reveals the graded and non-linear impact of a KCNE1 mutation on mefenamic acid's activation of IKs channels.

## Key findings

- The presence of K41C-KCNE1 subunits reduces mefenamic acid's potency in a graded and stoichiometric manner.
- Wild-type IKs subunits activate more quickly than K41C-IKs subunits in the presence of mefenamic acid.
- Voltage sensor kinetics are enhanced in WT IKs subunits, preceding activation of K41C-IKs subunits.

## Abstract

The IKs current formed by the co-assembly of KCNE1 and KCNQ1 plays an important role in cardiac repolarization. Mefenamic acid, an NSAID, is known to enhance IKs currents and has in turn been suggested as a therapeutic starting point for the development of compounds for the treatment of long QT syndrome. Our previous examinations of mefenamic acid’s action revealed that residue K41 on KCNE1 was critical for mefenamic acid’s activating effect on fully KCNE1 saturated, and partially saturated IKs channel complexes. The present study extends our previous work by incorporating the K41C-KCNE1 mutation into individual subunits to destabilize local mefenamic acid binding and explore how many of the remaining mefenamic acid-bound WT KCNE1-KCNQ1 subunits are required to support the activating action of the drug. Our results show that the potency of mefenamic acid action is reduced by the presence of K41C-KCNE1 subunits in a graded and stoichiometric, but non-linear manner. Modeling results are consistent with the idea that WT IKs subunits, in the presence of mefenamic acid, precede activation of K41C-IKs subunits due to their augmented voltage sensor kinetics.

## Linked entities

- **Genes:** KCNE1 (potassium voltage-gated channel subfamily E regulatory subunit 1) [NCBI Gene 3753], KCNQ1 (potassium voltage-gated channel subfamily Q member 1) [NCBI Gene 3784]
- **Chemicals:** mefenamic acid (PubChem CID 4044)
- **Diseases:** long QT syndrome (MONDO:0002442)

## Full-text entities

- **Genes:** KCNQ1 (potassium voltage-gated channel subfamily Q member 1) [NCBI Gene 3784] {aka ATFB1, ATFB3, JLNS1, KCNA8, KCNA9, KVLQT1}, IGLV2-8 (immunoglobulin lambda variable 2-8) [NCBI Gene 28817] {aka IGLV28, V1-2}, KCNE1 (potassium voltage-gated channel subfamily E regulatory subunit 1) [NCBI Gene 3753] {aka ISK, JLNS, JLNS2, LQT2/5, LQT5, MinK}, KCNQ1 (potassium voltage-gated channel subfamily Q member 1) [NCBI Gene 483669], KCNE1 (potassium voltage-gated channel subfamily E regulatory subunit 1) [NCBI Gene 487743]
- **Diseases:** long QT syndrome (MESH:D008133)
- **Chemicals:** L-364,373 (MESH:C113498), Lipofectamine2000 (MESH:C086724), HMR1556 (MESH:C420023), EQ (-), ML277 (MESH:C576869), Mefenamic acid (MESH:D008528), zinc pyrithione (MESH:C010423)
- **Species:** Canis lupus familiaris (dog, subspecies) [taxon 9615], Homo sapiens (human, species) [taxon 9606], Cavia porcellus (domestic guinea pig, species) [taxon 10141], Xenopus laevis (African clawed frog, species) [taxon 8355]
- **Mutations:** K41C, K41C
- **Cell lines:** 293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), CHO — Cricetulus griseus (Chinese hamster), Spontaneously immortalized cell line (CVCL_0213), LM — Homo sapiens (Human), Astrocytoma, Cancer cell line (CVCL_A1IU), tsA201 — Homo sapiens (Human), Transformed cell line (CVCL_2737), COS-7 — Chlorocebus aethiops (Green monkey), Transformed cell line (CVCL_0224)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12309529/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12309529/full.md

## References

19 references — full list in the complete paper: https://tomesphere.com/paper/PMC12309529/full.md

---
Source: https://tomesphere.com/paper/PMC12309529